Pleural and Mediastinal Malignancies最新文献_第2页

Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients 呼吸分析可以预测恶性胸膜间皮瘤患者的治疗反应

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1516

E. Schillebeeckx, E. Janssens, V. Surmont, K. Nackaerts, J. V. van Meerbeeck, K. Lamote

引用次数: 0

Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion 肌肉减少症对恶性胸腔积液患者长期症状的影响

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3100

Janet Rodríguez Torres, L. López-López, María Granados-Santiago, Esther Prados-Román, Alejandro Heredia-Ciuró, M. Valenza

引用次数: 0

Variation in outcomes for M1a Stage Lung cacers- Outcome in Malingnat Pleural Effusion significantly worse than patients with Contralateral Lung Nodules M1a期肺癌预后的变化——马林纳特胸腔积液患者的预后明显差于对侧肺结节患者

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3101

Sayed Alderazi, Anne Karanuatilleke, B. Sutton

引用次数: 0

The relationship between pleural effusion, neural respiratory drive and breathlessness – preliminary results from the SINE study 胸腔积液、神经呼吸驱动和呼吸困难之间的关系——sin研究的初步结果

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1519

P. Sivakumar, N. Shah, G. Kaltsakas, N. Hart, Patrick J. Murphy, L. Ahmed

引用次数: 0

The frequency of BAP1 and MTAP loss in Benign Asbestos-associated Pleural Inflammation 良性石棉相关胸膜炎症中BAP1和MTAP丢失的频率

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1522

K. Ferguson, Nicola Hyndman, F. Roberts, K. Blyth

引用次数: 0

Intracavitary anaesthesia for medical thoracoscopy: a randomised trial 医用胸腔镜腔内麻醉:一项随机试验

Pleural and Mediastinal Malignancies Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1520

M. Gadallah, M. Shaheen, S. Mourad, A. Abdelhady, Maged Hassan

引用次数: 0

Feasibility of thoracic ultrasound to assess the withdrawal of the indwelling pleural catheter. Concordance with chest CT scan 胸部超声评价胸腔留置导尿管拔除的可行性。胸部CT扫描吻合

Pleural and Mediastinal Malignancies Pub Date : 2019-09-28 DOI: 10.1183/13993003.congress-2019.oa491

Miguel Iglesias Heras, R. C. Pérez, Juan Alejandro Cascón Hernández, J. Hierro, José Ángel Tapias Del Pozo, T. A. García, Emilio Juárez Moreno, Roberto Fernández Mellado, Esther Yagüe Zapatero, Graciliano Estrada Trigeros, M. Ferrero

引用次数: 0

Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer 早期胸膜液控制是必要的，以防止恶性胸腔积液的再积累癌基因驱动的肺癌

Pleural and Mediastinal Malignancies Pub Date : 2019-09-28 DOI: 10.1183/13993003.congress-2019.oa3794

M. Lui, K. Chiang, Chung-man. Ho, C. Tam, C. Lam, Y. Lee, S. M. Ip

引用次数: 0

Meeting the National Mesothelioma Audit standards in clinical practice: How achievable is it? 在临床实践中达到国家间皮瘤审计标准:如何实现?

Pleural and Mediastinal Malignancies Pub Date : 2019-09-28 DOI: 10.1183/13993003.congress-2019.pa3097

E. Romer, L. Watkins, F. Frost, M. Ledson

{"title":"Meeting the National Mesothelioma Audit standards in clinical practice: How achievable is it?","authors":"E. Romer, L. Watkins, F. Frost, M. Ledson","doi":"10.1183/13993003.congress-2019.pa3097","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa3097","url":null,"abstract":"Introduction: The National Mesothelioma Audit Report 2018 highlighted variability in care of patients diagnosed with malignant mesothelioma (Royal College of Physicians, 2018; 9-11). We reviewed our practice during 2014-2018. Methods: Data for mesothelioma diagnoses in 2014-18 were obtained from the Somerset Cancer Registry and electronic patient records. Results: 59 patient notes were reviewed; 84.7% were male. Mean age was 75 years (range 50-90). Performance status (PS) was recorded in 55 (93.2%). 44 (74.6%) patients had video-assisted thoracoscopic surgery (VATS). 56 (94.9%) had pathological confirmation of mesothelioma; with pathological subtype in 44 (74.6%). 3 patients had no pathological confirmation. 2 were not investigated further due to PS 3; both died within 50 days of diagnosis. 1 had an inconclusive biopsy and the MDT felt histology would not change management. 30 (50.8%) received anti-cancer treatment: 20 (33.9%) chemotherapy, 14 (23.7%) radiotherapy (4 patients both). 17 of 37 patients with PS 0-1 received chemotherapy (45.9%). Conclusion: Audit standards were exceeded in recording PS and obtaining pathological diagnosis, but not in recording pathological subtype (Table 1). Chemotherapy rate was lower than expected despite all PS 0-1 patients being referred to oncology. This could be due to rapidly declining PS or patient choice. The findings highlight the aggressive nature of the disease and impact on treatment options.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89875133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion 了解临床实践的变化如何影响恶性胸腔积液患者的住院时间

Pleural and Mediastinal Malignancies Pub Date : 2019-09-28 DOI: 10.1183/13993003.congress-2019.pa3093

Carmen Tan, P. Quek, R. Chang

{"title":"Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion","authors":"Carmen Tan, P. Quek, R. Chang","doi":"10.1183/13993003.congress-2019.pa3093","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa3093","url":null,"abstract":"Background: Malignant pleural effusion (MPE) is a rising healthcare burden requiring inpatient care. Variation in clinical practice results in prolonged length of stay (LOS) for this vulnerable group where life expectancy is already compromised. Chest tube drainage remains the preferred local treatment with talc pleurodesis being performed as guided by patients’ suitability and preference. An institution-based clinical audit in 2016 revealed a median effusion related LOS of >7 days. This review aims to identify factors contributing to prolonged pleural drainage and implement strategies to improve management of MPE by reducing hospital stay. Methods: We identified factors of delay in chest tube removal from baseline data (n=53) and implemented targeted interventions over 3 months: 1. Spreading the word to stakeholders (Respiratory Medicine, Palliative Medicine, General Medicine, Radiology) involved; 2. Collaboration with Pathology/molecular laboratory for timely reporting of results; 3. Regular reminder and education of clinical staff regarding evidence-based practice; 4. Implementation of a practical guide/checklist for chest tube management and talc pleurodesis; 5. Talc pleurodesis Procedure Information Sheet. Results: The data of 61 patients during and post intervention between 1 Jun 2017 and 28 Feb 2018 was analysed. Median effusion related LOS decreased from >7 to 5 days. This improvement continued to sustain 6 months after implementation of all interventions. Conclusion: Through education and collaborative efforts in building partnerships, we achieved success in improving management of MPE and reducing effusion related LOS whilst maintaining quality care.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75747519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0